Evaluation of Complication Rates Using Filter vs. Centrifuge and Heparin vs. Citrate Anticoagulation

CompletedOBSERVATIONAL
Enrollment

108

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

December 31, 2019

Study Completion Date

February 4, 2024

Conditions
Therapeutic Plasma ExchangeAnticoagulant Therapy
Interventions
DEVICE

Active Comparator: centrifuge TPE with citrate

Patients who received citrate-based anticoagulation with centrifuge TPE

DEVICE

Active Comparator: Filter TPE with heparin

Patients who received heparin-based anticoagulation with filter TPE

DRUG

Active comparator: Filter TPE with citrate

Patients who received citrate-based anticoagulation with filter TPE

Trial Locations (1)

35233

University of Alabama, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT04351438 - Evaluation of Complication Rates Using Filter vs. Centrifuge and Heparin vs. Citrate Anticoagulation | Biotech Hunter | Biotech Hunter